Faeth Therapeutics
Faeth Therapeutics is pioneering a new treatment paradigm for cancer by leveraging metabolism and computational biology. The company focuses on a multi-nodal treatment approach that fully inhibits cancer cell growth, utilizing machine learning to develop therapies that target metabolic pathways. With a data-driven and evidence-based methodology, Faeth aims to improve patient outcomes through precision nutrition and tailored treatment regimens. Their lead program targets the PI3K/AKT/mTOR pathway, and they are currently conducting multiple clinical trials to validate their innovative approach.
Faeth Therapeutics
Faeth Therapeutics is pioneering a new treatment paradigm for cancer by leveraging metabolism and computational biology. The company focuses on a multi-nodal treatment approach that fully inhibits cancer cell growth, utilizing machine learning to develop therapies that target metabolic pathways. With a data-driven and evidence-based methodology, Faeth aims to improve patient outcomes through precision nutrition and tailored treatment regimens. Their lead program targets the PI3K/AKT/mTOR pathway, and they are currently conducting multiple clinical trials to validate their innovative approach.